| The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis DP Leong, F Caron, C Hillis, A Duan, JS Healey, G Fraser, D Siegal Blood, The Journal of the American Society of Hematology 128 (1), 138-140, 2016 | 254 | 2016 |
| Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials C Chai‐Adisaksopha, C Hillis, T Isayama, W Lim, A Iorio, M Crowther Journal of Thrombosis and Haemostasis 13 (11), 2012-2020, 2015 | 218 | 2015 |
| Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis C Chai-Adisaksopha, C Hillis, DM Siegal, R Movilla, N Heddle, A Iorio, ... Thrombosis and haemostasis 116 (11), 879-890, 2016 | 180 | 2016 |
| McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome K Legault, H Schunemann, C Hillis, C Yeung, EA Akl, M Carrier, ... Journal of Thrombosis and Haemostasis 16 (8), 1656-1664, 2018 | 140 | 2018 |
| Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study S Verstovsek, AT Gerds, AM Vannucchi, HK Al-Ali, D Lavie, ... The Lancet 401 (10373), 269-280, 2023 | 112 | 2023 |
| Major arterial events in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a meta-analysis C Chai-Adisaksopha, W Lam, C Hillis Leukemia & lymphoma 57 (6), 1300-1310, 2016 | 105 | 2016 |
| Current understanding of bleeding with ibrutinib use: a systematic review and meta-analysis F Caron, DP Leong, C Hillis, G Fraser, D Siegal Blood Advances 1 (12), 772-778, 2017 | 104 | 2017 |
| Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding C Chai-Adisaksopha, C Hillis, M Monreal, DM Witt, M Crowther Thrombosis and haemostasis 114 (10), 819-825, 2015 | 102 | 2015 |
| Hemodialysis for the treatment of dabigatran‐associated bleeding: a case report and systematic review C Chai‐Adisaksopha, C Hillis, W Lim, K Boonyawat, K Moffat, M Crowther Journal of Thrombosis and Haemostasis 13 (10), 1790-1798, 2015 | 95 | 2015 |
| Investigation and management of erythrocytosis S Mithoowani, M Laureano, MA Crowther, CM Hillis Cmaj 192 (32), E913-E918, 2020 | 66 | 2020 |
| Strategies for eliciting and synthesizing evidence for guidelines in rare diseases M Pai, CHT Yeung, EA Akl, A Darzi, C Hillis, K Legault, JJ Meerpohl, ... BMC medical research methodology 19, 1-10, 2019 | 64 | 2019 |
| Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: a systematic review and meta-analysis D Little, C Chai-Adisaksopha, C Hillis, DM Witt, M Monreal, MA Crowther, ... Thrombosis research 175, 102-109, 2019 | 58 | 2019 |
| Benefits and risks of antithrombotic therapy in essential thrombocythemia: a systematic review DK Chu, CM Hillis, DP Leong, SS Anand, DM Siegal Annals of Internal Medicine 167 (3), 170-180, 2017 | 55 | 2017 |
| Gender and BCR‐ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia HX Lin, J Sjaarda, J Dyck, R Stringer, C Hillis, M Harvey, R Carter, ... European journal of haematology 96 (4), 360-366, 2016 | 55 | 2016 |
| Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants CM Hillis, MA Crowther Thrombosis and Haemostasis 113 (06), 1193-1202, 2015 | 50 | 2015 |
| Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis C Chai-Adisaksopha, A Iorio, C Hillis, D Siegal, DM Witt, S Schulman, ... Thrombosis Research 160, 97-104, 2017 | 43 | 2017 |
| Bruton’s tyrosine kinase inhibitors and cardiotoxicity: more than just atrial fibrillation M Sestier, C Hillis, G Fraser, D Leong Current oncology reports 23 (10), 113, 2021 | 38 | 2021 |
| Genetic testing for thrombophilia-related genes: observations of testing patterns for factor V Leiden (G1691A) and prothrombin gene “Mutation”(G20210A) EJ Favaloro Seminars in thrombosis and hemostasis 45 (07), 730-742, 2019 | 34 | 2019 |
| Sex‐mismatched red blood cell transfusions and mortality: a systematic review and meta‐analysis MP Zeller, B Rochwerg, E Jamula, N Li, C Hillis, JP Acker, RJR Runciman, ... Vox sanguinis 114 (5), 505-516, 2019 | 33 | 2019 |
| Devices to reduce the volume of blood taken for laboratory testing in ICU patients: a systematic review DM Siegal, N Manning, NL Jackson Chornenki, CM Hillis, NM Heddle Journal of Intensive Care Medicine 35 (10), 1074-1079, 2020 | 31 | 2020 |
